Free Trial

QT Imaging (QTI) Competitors

QT Imaging logo
$1.94 -0.26 (-11.82%)
As of 07/11/2025

QTI vs. TLSI, INGN, SGHT, PROF, CVRX, KRMD, ELMD, PDEX, LNSR, and RCEL

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include TriSalus Life Sciences (TLSI), Inogen (INGN), Sight Sciences (SGHT), Profound Medical (PROF), CVRx (CVRX), KORU Medical Systems (KRMD), Electromed (ELMD), Pro-Dex (PDEX), LENSAR (LNSR), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

QT Imaging vs. Its Competitors

TriSalus Life Sciences (NASDAQ:TLSI) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 27.5% of TriSalus Life Sciences shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

QT Imaging has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -84.67%.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-84.67% N/A -111.63%
QT Imaging N/A N/A -65.94%

TriSalus Life Sciences presently has a consensus target price of $10.75, indicating a potential upside of 119.84%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe TriSalus Life Sciences is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

QT Imaging has lower revenue, but higher earnings than TriSalus Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$29.43M6.29-$30.05M-$1.12-4.37
QT Imaging$4.00M13.17-$4.03MN/AN/A

TriSalus Life Sciences has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500.

In the previous week, QT Imaging had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 2 mentions for QT Imaging and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.89 beat QT Imaging's score of 1.11 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
TriSalus Life Sciences Very Positive
QT Imaging Positive

Summary

TriSalus Life Sciences and QT Imaging tied by winning 7 of the 14 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$52.64M$32.88M$5.55B$9.11B
Dividend YieldN/AN/A5.07%4.01%
P/E RatioN/A3.2328.2120.26
Price / Sales13.17195.05432.0099.74
Price / CashN/A41.3637.1257.67
Price / Book-1.022.058.045.49
Net Income-$4.03M-$25.54M$3.19B$250.45M
7 Day Performance36.81%4.51%3.63%4.79%
1 Month Performance148.72%37.08%4.06%7.68%
1 Year Performance170.12%128.56%30.02%16.44%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
N/A$1.94
-11.8%
N/A+210.3%$52.64M$4.00M0.00N/ANews Coverage
Positive News
Gap Up
TLSI
TriSalus Life Sciences
3.0258 of 5 stars
$5.17
+4.2%
$10.75
+107.9%
-8.8%$195.63M$32.14M-4.62106
INGN
Inogen
4.3382 of 5 stars
$7.26
flat
$11.00
+51.5%
-23.1%$195.20M$339.96M-6.311,030News Coverage
SGHT
Sight Sciences
1.5511 of 5 stars
$3.55
+2.3%
$4.10
+15.5%
-54.7%$183.54M$79.87M-3.62210
PROF
Profound Medical
2.7362 of 5 stars
$5.99
-1.6%
$11.50
+92.0%
-37.2%$180M$10.68M-4.91150
CVRX
CVRx
3.1057 of 5 stars
$6.75
+2.4%
$14.50
+114.8%
-19.7%$175.97M$51.29M-3.10160News Coverage
Positive News
Analyst Revision
KRMD
KORU Medical Systems
2.6902 of 5 stars
$3.80
+3.5%
$4.50
+18.4%
+31.8%$175.33M$33.65M-34.5580Positive News
ELMD
Electromed
0.8687 of 5 stars
$20.02
-0.5%
$38.00
+89.8%
+31.3%$167.89M$61.44M26.69160
PDEX
Pro-Dex
2.5052 of 5 stars
$47.69
+3.2%
$56.00
+17.4%
+156.5%$155.47M$53.84M17.03140Positive News
LNSR
LENSAR
1.3049 of 5 stars
$13.14
+2.3%
$15.00
+14.2%
+179.6%$154.92M$53.49M-2.71110News Coverage
RCEL
Avita Medical
1.3691 of 5 stars
$5.61
+8.5%
$16.50
+194.1%
-35.2%$148.27M$64.25M-2.56130

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners